183 related articles for article (PubMed ID: 31077012)
1. Estrogen-independent role of ERα in ovarian cancer progression induced by leptin/Ob-Rb axis.
Ghasemi A; Saeidi J; Mohtashami M; Hashemy SI
Mol Cell Biochem; 2019 Aug; 458(1-2):207-217. PubMed ID: 31077012
[TBL] [Abstract][Full Text] [Related]
2. Leptin induces matrix metalloproteinase 7 expression to promote ovarian cancer cell invasion by activating ERK and JNK pathways.
Ghasemi A; Hashemy SI; Aghaei M; Panjehpour M
J Cell Biochem; 2018 Feb; 119(2):2333-2344. PubMed ID: 28885729
[TBL] [Abstract][Full Text] [Related]
3. RhoA/ROCK pathway mediates leptin-induced uPA expression to promote cell invasion in ovarian cancer cells.
Ghasemi A; Hashemy SI; Aghaei M; Panjehpour M
Cell Signal; 2017 Apr; 32():104-114. PubMed ID: 28104444
[TBL] [Abstract][Full Text] [Related]
4. Estradiol promotes cell survival and induces Greb1 expression in granulosa cell tumors of the ovary through an ERα-dependent mechanism.
Cluzet V; Devillers MM; Petit F; Pierre A; Giton F; Airaud E; L'Hôte D; Leary A; Genestie C; Treilleux I; Mayeur A; Katzenellenbogen JA; Kim SH; Cohen-Tannoudji J; Chauvin S; Guigon CJ
J Pathol; 2022 Mar; 256(3):335-348. PubMed ID: 34860414
[TBL] [Abstract][Full Text] [Related]
5. Effects of oestrogen on long noncoding RNA expression in oestrogen receptor alpha-positive ovarian cancer cells.
Qiu J; Ye L; Ding J; Feng W; Zhang Y; Lv T; Wang J; Hua K
J Steroid Biochem Mol Biol; 2014 May; 141():60-70. PubMed ID: 24380700
[TBL] [Abstract][Full Text] [Related]
6. Stage specific effect of leptin on the expressions of estrogen receptor and extracellular matrix in a model of chondrocyte differentiation.
Li XF; Wang SJ; Jiang LS; Dai LY
Cytokine; 2013 Mar; 61(3):876-84. PubMed ID: 23357303
[TBL] [Abstract][Full Text] [Related]
7. Role of GPER on proliferation, migration and invasion in ligand-independent manner in human ovarian cancer cell line SKOV3.
Yan Y; Jiang X; Zhao Y; Wen H; Liu G
Cell Biochem Funct; 2015 Dec; 33(8):552-9. PubMed ID: 26526233
[TBL] [Abstract][Full Text] [Related]
8. Cellular and molecular crosstalk between leptin receptor and estrogen receptor-{alpha} in breast cancer: molecular basis for a novel therapeutic setting.
Fusco R; Galgani M; Procaccini C; Franco R; Pirozzi G; Fucci L; Laccetti P; Matarese G
Endocr Relat Cancer; 2010 Jun; 17(2):373-82. PubMed ID: 20410173
[TBL] [Abstract][Full Text] [Related]
9. Superactive human leptin antagonist (SHLA), triple Lan1 and quadruple Lan2 leptin mutein as a promising treatment for human folliculoma.
Fiedor E; Gregoraszczuk EL
Cancer Chemother Pharmacol; 2017 Oct; 80(4):815-827. PubMed ID: 28861689
[TBL] [Abstract][Full Text] [Related]
10. Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer.
Chen X; Zha X; Chen W; Zhu T; Qiu J; Røe OD; Li J; Wang Z; Yin Y
Biomed Pharmacother; 2013 Feb; 67(1):22-30. PubMed ID: 23199901
[TBL] [Abstract][Full Text] [Related]
11. Differential induction of LRP16 by liganded and unliganded estrogen receptor alpha in SKOV3 ovarian carcinoma cells.
Tian L; Wu Z; Zhao Y; Meng Y; Si Y; Fu X; Mu Y; Han W
J Endocrinol; 2009 Jul; 202(1):167-77. PubMed ID: 19403568
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor alpha pathway is involved in leptin-induced ovarian cancer cell growth.
Choi JH; Lee KT; Leung PC
Carcinogenesis; 2011 Apr; 32(4):589-96. PubMed ID: 21173433
[TBL] [Abstract][Full Text] [Related]
13. Non-genomic estrogen/estrogen receptor α promotes cellular malignancy of immature ovarian teratoma in vitro.
Hung YC; Chang WC; Chen LM; Chang YY; Wu LY; Chung WM; Lin TY; Chen LC; Ma WL
J Cell Physiol; 2014 Jun; 229(6):752-61. PubMed ID: 24142535
[TBL] [Abstract][Full Text] [Related]
14. Activation of estrogen receptor α by estradiol and cisplatin induces platinum-resistance in ovarian cancer cells.
Matsumura S; Ohta T; Yamanouchi K; Liu Z; Sudo T; Kojimahara T; Seino M; Narumi M; Tsutsumi S; Takahashi T; Takahashi K; Kurachi H; Nagase S
Cancer Biol Ther; 2017 Sep; 18(9):730-739. PubMed ID: 27689466
[TBL] [Abstract][Full Text] [Related]
15. Expression and clinical significance of estrogen-regulated long non-coding RNAs in estrogen receptor α-positive ovarian cancer progression.
Qiu JJ; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ
Oncol Rep; 2014 Apr; 31(4):1613-22. PubMed ID: 24481591
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis.
Chan KKL; Siu MKY; Jiang YX; Wang JJ; Wang Y; Leung THY; Liu SS; Cheung ANY; Ngan HYS
BMC Cancer; 2017 Aug; 17(1):606. PubMed ID: 28859612
[TBL] [Abstract][Full Text] [Related]
17. The expression and correlation between the transcription factor FOXP1 and estrogen receptors in epithelial ovarian cancer.
Hu Z; Zhu L; Tan M; Cai M; Deng L; Yu G; Liu D; Liu J; Lin B
Biochimie; 2015 Feb; 109():42-8. PubMed ID: 25500588
[TBL] [Abstract][Full Text] [Related]
18. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
[TBL] [Abstract][Full Text] [Related]
19. microRNA-206 overexpression inhibits cellular proliferation and invasion of estrogen receptor α-positive ovarian cancer cells.
Li S; Li Y; Wen Z; Kong F; Guan X; Liu W
Mol Med Rep; 2014 May; 9(5):1703-8. PubMed ID: 24604205
[TBL] [Abstract][Full Text] [Related]
20. Role of estrogen receptor-alpha and -beta in regulating leptin expression in 3T3-L1 adipocytes.
Yi KW; Shin JH; Seo HS; Lee JK; Oh MJ; Kim T; Saw HS; Kim SH; Hur JY
Obesity (Silver Spring); 2008 Nov; 16(11):2393-9. PubMed ID: 18719660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
